Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-024568
Filing Date
2022-02-01
Accepted
2022-02-01 16:02:14
Documents
6
Effectiveness Date
2022-02-01

Document Format Files

Seq Description Document Type Size
1 S-8 d125972ds8.htm S-8 68907
2 EX-5.1 d125972dex51.htm EX-5.1 12447
3 EX-23.1 d125972dex231.htm EX-23.1 2043
4 EX-23.2 d125972dex232.htm EX-23.2 1555
5 EX-FILING FEES d125972dexfilingfees.htm EX-FILING FEES 24564
6 GRAPHIC g125972g45u02.jpg GRAPHIC 3774
  Complete submission text file 0001193125-22-024568.txt   116000
Mailing Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140
Business Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140 (305) 204-3338
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262452 | Film No.: 22578850
SIC: 2836 Biological Products, (No Diagnostic Substances)